As the buzz increases in volume and the clock to kick-off counts down, keep an eye on this Spotlight On page for content ...

Citylabs 4.0, now open in the heart of Manchester’s Knowledge Quarter on the Oxford Road Corridor, was built with exactly ...

Added to that, 23andMe suffered a massive data breach in 2023 that resulted in information from about 7 million people being ...

The tantalising development has been reported by researchers at the Peter Doherty Institute for Infection and Immunity in ...

A long-acting medicine developed by Novo Nordisk has been recommended as a treatment option for young people with growth ...

At ASCO 2025, Servier presented data in the IDH-mutated cancer space.

It is the first fundraising effort at Neuralink since its $280 million Series D round in 2023 and brings the company's total ...

The 5th iPSC Drug Development Summit serves as a pivotal platform for uniting iPSC-based drug developers across the value ...

Europe follows a similar pattern, with data from the EU Clinical Trials Information System (CTIS) estimating that less than 0 ...

Meanwhile, the MHRA has also warned all people seeking treatment with the so-called "skinny jabs" to beware of counterfeit ...

At ASCO 2025, pharmaphorum web editor Nicole Raleigh sat down to discuss key highlights from the Congress with EVERSANA experts.

Akeega – which combines the active ingredients in J&J's PARP inhibitor Zejula (niraparib) and androgen blocker Zytiga ...